Lauren Stival | Senior Director, IR & Corporate Communications |
Michael Anderson | Chief Executive Officer |
Michael Kanan | Senior Vice President and Chief Financial Officer |
David Monteith | Vice President of Research and Development |
Gregory Divis | Executive Vice President and Chief Commercial Officer |
John Boris | SunTrust Robinson Humphrey Inc. |
Francois Brisebois | Laidlaw & Company Ltd. |
Matthew Kaplan | Ladenburg Thalmann & Co. |
Scott Henry | ROTH Capital Partners, LLC |
Good day, ladies and gentlemen, and welcome to the Avadel Pharmaceuticals Fourth Quarter and Full-Year 2017 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we’ll conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions].
As a reminder, this conference may be recorded.